283 related articles for article (PubMed ID: 2545982)
21. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
Spadari S; Ciarrocchi G; Focher F; Verri A; Maga G; Arcamone F; Iafrate E; Manzini S; Garbesi A; Tondelli L
Mol Pharmacol; 1995 Jun; 47(6):1231-8. PubMed ID: 7603465
[TBL] [Abstract][Full Text] [Related]
22. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
23. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector.
Hoggarth JH; Jones E; Ensser A; Meredith DM
Cancer Gene Ther; 2004 Sep; 11(9):613-24. PubMed ID: 15243631
[TBL] [Abstract][Full Text] [Related]
24. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
[TBL] [Abstract][Full Text] [Related]
25. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
[TBL] [Abstract][Full Text] [Related]
26. (E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.
Bernaerts R; Desgranges C; De Clercq E
Biochem Pharmacol; 1989 Jun; 38(12):1955-61. PubMed ID: 2545207
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate potentiates anti-herpes simplex virus type 1 activity of E-5-(2-bromovinyl)-2'-deoxyuridine.
Pancheva SN
Acta Virol; 1995 Apr; 39(2):117-9. PubMed ID: 7676937
[TBL] [Abstract][Full Text] [Related]
28. Establishment of mutant FM3A murine mammary carcinoma cell strains transformed with the herpes simplex virus type 1 thymidine kinase gene.
Ayusawa D; Shimizu K; Seno T; Balzarini J; De Clercq E
Jpn J Cancer Res; 1985 Oct; 76(10):984-8. PubMed ID: 3001011
[TBL] [Abstract][Full Text] [Related]
29. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
[TBL] [Abstract][Full Text] [Related]
30. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
[No Abstract] [Full Text] [Related]
31. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells.
Panet A; Falk H
J Gen Virol; 1983 Sep; 64 (Pt 9)():1999-2006. PubMed ID: 6193244
[TBL] [Abstract][Full Text] [Related]
33. Selective antiherpetic activity of carbocyclic analogues of (E)-5-(2-halogenovinyl)-2'-deoxyuridines: dependence on specific phosphorylation by viral thymidine kinase.
De Clercq E; Balzarini J; Bernaerts R; Herdewijn P; Verbruggen A
Biochem Biophys Res Commun; 1985 Jan; 126(1):397-403. PubMed ID: 2982373
[TBL] [Abstract][Full Text] [Related]
34. Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Fyfe JA; McKee SA; Keller PM
Mol Pharmacol; 1983 Sep; 24(2):316-23. PubMed ID: 6310366
[TBL] [Abstract][Full Text] [Related]
35. The effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on DNA repair and mutagenesis of herpes simplex virus type 1.
Bubley GJ; Balzarini J; Crumpacker CS; de Clercq E; Schnipper LE
Virology; 1987 Nov; 161(1):242-4. PubMed ID: 2823464
[TBL] [Abstract][Full Text] [Related]
36. Differential inhibition of herpes simplex viruses, type 1 (HSV-1) an type 2 (HSV-2), by (E)-5-(2-X-vinyl)-2'-deoxyuridines.
de Clercq E; Verhelst G; Descamps J; Bergstrom DE
Acta Microbiol Acad Sci Hung; 1981; 28(3):307-12. PubMed ID: 6272553
[No Abstract] [Full Text] [Related]
37. [Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell].
Liang Z; Kuang J; Lin Z
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):467-70. PubMed ID: 9639739
[TBL] [Abstract][Full Text] [Related]
38. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
39. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
40. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
Wildner O; Blaese RM; Candotti F
Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
